Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ZL-1310 |
Trade Name | |
Synonyms | ZL1310|ZL 1310|YL212|YL 212|YL-212|ADC SC-002 |
Drug Descriptions |
ZL-1310 is an antibody-drug conjugate (ADC) comprising an antibody targeting DLL3 linked to a camptothecin derivative, which potentially inhibits tumor growth (ESMO Open, Volume 9, 102891). |
DrugClasses | DLL3 Antibody 6 |
CAS Registry Number | NA |
NCIT ID | C203531 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ZL-1310 | ZL-1310 | 0 | 1 |